Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy Sistemik Lipozomal Amfoterisin B Tedavisine Cevap Veren Kutanöz Leishmaniasis Olgusu

YEŞİLOVA, YAVUZ; Turan, Enver; Sürücü, Hacer; Aksoy, Mustafa; Özbilgin, Ahmet

doi:10.5152/tpd.2015.3761

Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy Sistemik Lipozomal Amfoterisin B Tedavisine Cevap Veren Kutanöz Leishmaniasis Olgusu

YEŞİLOVA Y., Turan E., Sürücü H. A., Aksoy M., Özbilgin A.

Türkiye parazitolojii dergisi / Türkiye Parazitoloji Derneği = Acta parasitologica Turcica / Turkish Society for Parasitology, cilt.39, sa.1, ss.63-65, 2015 (Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 1
Basım Tarihi: 2015
Doi Numarası: 10.5152/tpd.2015.3761
Dergi Adı: Türkiye parazitolojii dergisi / Türkiye Parazitoloji Derneği = Acta parasitologica Turcica / Turkish Society for Parasitology
Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.63-65
Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Cutaneous Leishmaniasis (CL) is a skin infection caused by various species of Leishmania parasites, which is transmitted by infected Phlebotomus sandfly bites. Pentavalent antimonials (meglumine antimoniate and sodium stibogluconate) are used for the treatment of adult CL patients as an effective and safe method. Liposomal amphotericin B is an alternative for the treatment of choice in cutaneous leishmaniasis cases which pentavalan antimony contraindicated or unresponsive to pentavalent antimony therapy. In this study, successful treatment with systemic liposomal amphotericin B of a cutaneous leishmaniasis case developing local side effects related both systemic and intralesional meglumine antimonate treatment was presented.